Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02206724 | Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer | withdrawn | N/A | 0 | Sharp HealthCareOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT01188408 | Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | INSYS Therapeutics IncINDUSTRY | 1 | Mar 12, 2018 | clinicaltrials |
| Hypofractionated Whole Pelvic Radiotherapy of the Prostate |
| withdrawn |
| N/A |
| 0 |
| Albert J. ChangOTHER |
| 0 |
| Feb 12, 2018 |
| clinicaltrials |
| NCT00003534 | Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | withdrawn | Phase 1 / Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Dec 13, 2017 | clinicaltrials |
| NCT01260909 | Real-Time MV/kV Image Guided Radiation Therapy | withdrawn | — | 0 | Stanford UniversityOTHER | 0 | Dec 2, 2017 | clinicaltrials |
| NCT02793219 | Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT02793765 | Docetaxel Followed by Provenge in Metastatic Prostate Cancer | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT02232672 | Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer | withdrawn | N/A | 0 | Odense University HospitalOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT03173807 | Prostate Nutrition and Exercise STudy (ProNEST)(ProNEST) | withdrawn | N/A | 0 | University of PittsburghOTHER | 0 | Oct 6, 2017 | clinicaltrials |
| NCT02810886 | Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management(ProsPERo) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 0 | Aug 22, 2017 | clinicaltrials |
| NCT00003622 | Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | withdrawn | Phase 2 | 0 | James AhlgrenOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT00937417 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Apr 24, 2017 | clinicaltrials |
| NCT01087580 | Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Northwestern UniversityOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01748110 | Health Interventions in Men Undergoing Radical Prostatectomy(HIM-UP) | withdrawn | N/A | 0 | Johns Hopkins UniversityOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT00598858 | Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate(2007-5904) | withdrawn | Phase 2 | 0 | John P. FruehaufOTHER | 0 | Dec 8, 2016 | clinicaltrials |
| NCT02645591 | Randomized AmnioFix Study During Radical Prostatectomy | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Nov 22, 2016 | clinicaltrials |
| NCT00767845 | Symptom Management in African-American Men With Localized Prostate Cancer | withdrawn | — | 0 | Baylor College of MedicineOTHER | 1 | Nov 9, 2016 | clinicaltrials |
| NCT02656563 | Radium 223 Following Intermittent ADT(RAND) | withdrawn | Phase 2 | 0 | Canadian Urology Research ConsortiumOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT02169063 | Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer | withdrawn | N/A | 0 | University of WashingtonOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00691899 | A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT01379378 | Male Stress Urinary Incontinence and Sexual Health | withdrawn | — | 0 | Stanford UniversityOTHER | 1 | Jul 22, 2016 | clinicaltrials |
| NCT02678520 | Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | withdrawn | Phase 2 | 0 | University of Kansas Medical CenterOTHER | 1 | Jul 22, 2016 | clinicaltrials |
| NCT00003858 | Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | withdrawn | Phase 2 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2016 | clinicaltrials |
| NCT01658527 | TAK-700 in Castration Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 10, 2016 | clinicaltrials |
| NCT01173146 | Imaging of Residual Tumor During Prostatectomy | withdrawn | — | 0 | Spectros CorporationINDUSTRY | 1 | May 25, 2016 | clinicaltrials |
| NCT00801996 | Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries(ProstateCA) | withdrawn | — | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT02512120 | Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation(VCVAFVCV) | withdrawn | N/A | 0 | Korea University Anam HospitalOTHER | 0 | Apr 27, 2016 | clinicaltrials |
| NCT02110849 | Prostate Cancer Parameters for Patients Receiving Proton Treatment | withdrawn | — | 0 | Indiana UniversityOTHER | 1 | Apr 7, 2016 | clinicaltrials |
| NCT02035124 | Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel | withdrawn | Phase 2 | 0 | SCRI Development Innovations, LLCOTHER | 1 | Feb 11, 2016 | clinicaltrials |
| NCT02130947 | Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide | withdrawn | N/A | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 11, 2016 | clinicaltrials |
| NCT02621684 | Physical Activity Intervention in African American Men After Radical Prostatectomy | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 0 | Jan 29, 2016 | clinicaltrials |
| NCT02079155 | Robotic Athermal Nerve-Sparing Radical Prostatectomy | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jan 22, 2016 | clinicaltrials |
| NCT01279785 | A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy | withdrawn | — | 0 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT02396368 | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer(Radium-223) | withdrawn | Phase 1 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT01530984 | Ipilimumab and GMCSF Immunotherapy for Prostate Cancer | withdrawn | Phase 2 | 0 | Lawrence FongOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT01745718 | Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer | withdrawn | N/A | 0 | Oslo University HospitalOTHER | 1 | Sep 23, 2015 | clinicaltrials |
| NCT01368003 | STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling | withdrawn | Phase 2 | 0 | Toni Choueiri, MDOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT02022904 | Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology | withdrawn | N/A | 0 | Duke UniversityOTHER | 0 | Jul 30, 2015 | clinicaltrials |
| NCT01561482 | Study of Metformin With Simvastatin for Men With Prostate Carcinoma | withdrawn | Phase 2 | 0 | Nicholas MitsiadesOTHER | 1 | Jul 22, 2015 | clinicaltrials |
| NCT01520441 | BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) | withdrawn | Early Phase 1 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02424513 | A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer | withdrawn | Phase 2 | 0 | ImaginAb, Inc.INDUSTRY | 1 | Jun 2, 2015 | clinicaltrials |
| NCT02420587 | AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 20, 2015 | clinicaltrials |
| NCT01274572 | Blood for Immune Response to Provenge® in HRPC | withdrawn | — | 0 | Mary Crowley Medical Research CenterOTHER | 0 | Apr 7, 2015 | clinicaltrials |
| NCT00694291 | Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT01163448 | Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer | withdrawn | Phase 1 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT01565512 | Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort | withdrawn | Phase 1 / Phase 2 | 0 | Columbia UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02159690 | A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy | withdrawn | Phase 2 | 0 | Kenneth Pienta, MDOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02065323 | A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT | withdrawn | Phase 2 | 0 | Oscar Goodman, Jr.OTHER | 1 | Jan 19, 2015 | clinicaltrials |
| NCT01838265 | Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management(MGM) | withdrawn | — | 0 | University of MiamiOTHER | 1 | Dec 8, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Apr 20, 2018source: clinicaltrials